David Reiss joins Cornell Law School and Cornell Tech faculties

On July 1, Cornell Law School and Cornell Tech welcomed David Reiss to their faculties as clinical professor of law and research director of the Blassberg-Rice Center for Entrepreneurship Law.

Around Cornell

General anesthetic may lead to new epilepsy treatments

Propofol may hold the keys to developing new treatment strategies for epilepsy and other neurological disorders, according to a new study.

Cornell Tech Council Names New Chairman and Council Member

The Cornell Tech Council, the primary governance group for Cornell Tech and a subsidiary body of the Cornell University Board of Trustees, has announced the appointment of Howard Morgan Ph.D. ’68 as its new chairman and Adam…

Around Cornell

Study finds reliable performance for wireless pacemaker

A dual-chamber wireless pacemaker provides reliable performance over three months, bolstering evidence for this new option, according to results from a multi-center international clinical trial co-led by a Weill Cornell Medicine investigator.

Preclinical study explores approved drug for ovarian cancer

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.

Medicaid enrollees struggle to find psychiatric care

Many people enrolled in Medicaid who require psychiatric care have difficulty accessing clinicians in a timely manner despite the higher need in this population, according to a study by researchers at Weill Cornell Medicine.

Medicaid policies increase diversity in cancer clinical trials

Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania and Medidata AI.

Blood test may guide use of multiple myeloma immunotherapy

A simple blood test that measures the number of lymphocytes may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy.

Model offers insights into Parkinson’s disease process

A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease.